The FDA assessed the safety and efficiency of atidarsagene autotemcel dependant on information from 37 little ones who been given atidarsagene autotemcel in two one-arm, open up-label clinical trials As well as in an expanded access system.[7] Young children who gained treatment with atidarsagene au